Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge
International Journal of Molecular Sciences · 23.01.2023 · 24 (3) · 2264
DOI: 10.3390/ijms24032264 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.01.2023. Verfasst von Daniele Focosi und 4 weiteren Autor:innen. Beteiligte Einrichtung: North-Western Tuscany Blood Bank, Pisa University Hospital, 56124 Pisa, Italy. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The first 2 years of the COVID-19 pandemic were mainly characterized by recurrent mutations of SARS-CoV-2 Spike protein at residues K417, L452, E484, N501 and P681 emerging independently across different variants of concern (Alpha, Beta, Gamma, and Delta). Such homoplasy is a marker of convergent evolution. Since Spring 2022 and the third year of the pandemic, with the advent of Omicron and its sublineages, convergent evolution has led to the observation of different lineages acquiring an additional group of mutations at different amino acid residues, namely R346, K444, N450, N460, F486, F490, Q493, and S494. Mutations at these residues have become increasingly prevalent during Summer and Autumn 2022, with combinations showing increased fitness. The most likely reason for this convergence is the selective pressure exerted by previous infection- or vaccine-elicited immunity. Such accelerated evolution has caused failure of all anti-Spike monoclonal antibodies, including bebtelovimab and cilgavimab. While we are learning how fast coronaviruses can mutate and recombine, we should reconsider opportunities for economically sustainable escape-proof combination therapies, and refocus antibody-mediated therapeutic efforts on polyclonal preparations that are less likely to allow for viral immune escape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- North-Western Tuscany Blood Bank, Pisa University Hospital, 56124 Pisa, Italy.
- Instituto de Investigaciones en Físico-Química de Córdoba (INFIQC-CONICET), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Cordova 5000, Argentina.
- Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
- Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO 65201, USA.
ORCID-Profile: Daniele Focosi, Rodrigo Quiroga, Scott McConnell, Marc C Johnson, Arturo Casadevall
Förderung
- NIAID NIH HHS
Zitieren
APA
Focosi, D., Quiroga, R., McConnell, S., Johnson, M. C., & Casadevall, A. (2023). Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge. International Journal of Molecular Sciences, 24(3), 2264. https://doi.org/10.3390/ijms24032264
Vancouver
Focosi D, Quiroga R, McConnell S, Johnson MC, Casadevall A. Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge. International Journal of Molecular Sciences. 2023;24(3):2264. doi:10.3390/ijms24032264
BibTeX
@article{Focosi2023,
author = {Focosi, Daniele and Quiroga, Rodrigo and McConnell, Scott and Johnson, Marc C and Casadevall, Arturo},
title = {Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2264},
doi = {10.3390/ijms24032264}
}
EUVIMED